The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The network genomic medicine cost reimbursement model for implementation of comprehensive lung cancer genotyping in clinical routine.
 
Anna Kostenko
No Relationships to Disclose
 
Jan Peter Glossmann
No Relationships to Disclose
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer
Speakers' Bureau - AstraZeneca; Novartis
 
Juliane Sueptitz
No Relationships to Disclose
 
Matthias Scheffler
No Relationships to Disclose
 
Rieke Fischer
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb
 
Birgid Markiefka
No Relationships to Disclose
 
Andreas Scheel
No Relationships to Disclose
 
Peter De Mary
No Relationships to Disclose
 
Florian Kron
No Relationships to Disclose
 
Reinhard Buettner
No Relationships to Disclose
 
Juergen Wolf
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; MSD Oncology; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; MSD; Novartis; Pfizer; Roche Pharma AG
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst)